-
Mashup Score: 3
Physicians are beginning to face patient questions about commercially available tests without definitive utility data to guide them.
Source: GenomeWebCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0TAPESTRY Study Results Fuel Calls for Universal Genetic Testing for Hereditary Cancer Risk - 1 year(s) ago
An analysis of whole-exome sequencing results presented at AACR suggests many people with hereditary cancer risk variants don’t fall under current NCCN guidelines.
Source: GenomeWebCategories: Hem/Oncs, Latest HeadlinesTweet-
TAPESTRY Study Results Fuel Calls for Universal Genetic Testing for Hereditary Cancer Risk https://t.co/5wvTIzNxR1 #AACR23
-
-
Mashup Score: 0
The Bay Area company counts Ginkgo Bioworks among its customers for synthetic DNA molecules between 1 Kb and 7 Kb long.
Source: GenomeWebCategories: Healthcare Professionals, Latest HeadlinesTweet-
#SyntheticDNA Startup @ElegenBio Gains Traction With Customers, Funders https://t.co/fvQjKe23fs "Though Elegen has not yet fully revealed its manufacturing process, the fact that #Ginkgo — which possesses its own capabilities for making long #DNA through its acquisition of Gen9… https://t.co/lHBH0ajttE
-
-
Mashup Score: 1As Use of Large Cancer Panels and Whole-Genome Sequencing Expands, Illumina Plans to Future-Proof NGS Interpretation and Reporting - 1 year(s) ago
Illumina’s new software platform, designed to reduce tertiary analysis time and ease reporting, launches in multiple global markets as experts say the volume of clinical NGS data is ballooning.
Source: GenomeWebCategories: Hem/Oncs, Latest HeadlinesTweet-
Cancer is a genetic disease and best care requires deep analysis of each patient’s tumor. While ample genomic panels and WGS exist, I'm excited to see how Illumina Connected Insights will help the interpretation of sequencing data. https://t.co/0gXtiNlsLI
-
-
Mashup Score: 0International Team Develops New Method to Detect Protein Isoforms in the Human Proteome - 1 year(s) ago
The study identified more than 1 million peptides from 17,717 different protein groups from six human cell lines.
Source: GenomeWebCategories: Future of Medicine, Latest HeadlinesTweet-
@UWMadison_CGSI @GarvanInstitute @BMC_UW @univienna @DonnellyCentre @MPI_Biochem @Morgridge_Inst @TheCoxLab @Coon_Labs @ATGTAC International team develops new method to detect protein isoforms in the human proteome #NBTintheNews via @GenomeWeb https://t.co/EIR8bLaZPL
-
-
Mashup Score: 0
By mapping individual cells to a scRNA-seq atlas, the new computational method seeks to fill in missing pieces in transcriptomes and advance cancer drug discovery.
Source: GenomeWebCategories: Future of Medicine, Latest HeadlinesTweet-
Stanford's CytoSPACE looks to improve single-cell transcriptomics alignment #NBTintheNews https://t.co/1aJ2dUtPnA
-
-
Mashup Score: 0CRISPR Screens Reveal Heart Attack-Linked Gene - 1 year(s) ago
Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.
Source: GenomeWebCategories: Expert Picks, Latest HeadlinesTweet-
CRISPR Screens Reveal Heart Attack-Linked Gene https://t.co/S1lqxHaIXg
-
-
Mashup Score: 2
The researchers have already identified babies with G6PD deficiency who would have been missed by standard newborn screening.
Source: GenomeWebCategories: Hem/Oncs, Latest HeadlinesTweet-
A day 1 genome? Yes, Please! @TheACMG, @wendykchung presented the Guardian study from Columbia, New York-Presby, and the NY State DoH, @GeneDx, & @Illumina. High (74%) participation & 4% with findings. A great start to studying WGS for newborn screening! https://t.co/Jy1rhWXHty
-
-
Mashup Score: 0Most Patients With Inherited Heart Conditions Not Getting Guideline-Backed Genetic Testing - 1 year(s) ago
Researchers analyzed electronic health and claims records to discover very low genetic testing rates among patients with five inherited cardiovascular conditions.
Source: GenomeWebCategories: Hem/Oncs, Latest HeadlinesTweet-
Do cardiologists follow level I AHA recommendations? Only if rates of 1.4%-9.4% are good enough. Here, GenomeWeb highlights an abstract from ACC by HealthPals and Illumina leveraging real world data to identify (the lack of) guideline recommended testing https://t.co/nZyQKfBKsd
-
-
Mashup Score: 0
Developed at the University of Cambridge, Chem-map allows in situ mapping of small molecules that bind to cellular genomic DNA or chromatin-associated proteins.
Source: GenomeWebCategories: Future of Medicine, Latest HeadlinesTweet-
New method enables direct profiling of drug-chromatin binding in cells #NBTintheNews https://t.co/OSletFKiTM
-
Such an interesting and complex space scientifically and ethically 👉🏻 Clinical Concerns Dominate Multi-Cancer Early Detection Debate at AACR https://t.co/mTabAX4OMX